“There are three kinds of lies: lies, damned lies, and statistics.” – Mark Twain
“…most ‘flu’ appears to have nothing to do with influenza. Every year, hundreds of thousands of respiratory specimens are tested across the US. Of those tested, on average 16% are found to be influenza positive.” – From the British Medical Journal editor, Peter Doshi, MD
“71 people would need to be treated with the flu vaccine to prevent one case. In other words, the flu vaccine did nothing for 70 out of 71 who received it. That means this study found the flu vaccine failed 99% (70/71).” — Dr David Brownstein
“Under ideal conditions (when the vaccine actually matches the main viruses circulating that season) you need to vaccinate 33 healthy adults to avoid one set of influenza symptoms. 33 is what is called the NNV (Number Needed to Vaccinate).” – Dr Tom Jefferson of the Cochrane Collaboration (Cochrane Database Syst. Rev. 2018. Feb. 1,2:CD001269)
“…influenza virus often mutates to adapt to being grown in chicken eggs, which can influence antigenicity and hence vaccine effectiveness.” — Ian A. Wilson, MD, et al from: “A Structural Explanation for the Low Effectiveness of the Seasonal Influenza H3N2 Vaccine“
“Between 33 and 100 people are needed to vaccinate to prevent one case of flu symptoms.” – Alan Cassals, author of Selling Sickness: Medical Screening and the Misguided Hunt for Disease
“Normally, the flu vaccine is between 50 to 60 percent effective.” — Dr. Tom Frieden, Director of the Centers for Disease Control and Prevention (CDC)
Last year, the well-propagandized talking heads on TV and radio repeated over and over again how important it was to be fully vaccinated with the newest untried and unproven-for-effectiveness influenza vaccine, whose ingredients had been chosen 6 months earlier (in the spring of 2017) by industry “experts” who were forced to guess which 3 or 4 influenza viruses from the southern hemisphere (out of hundreds of potential viruses) that were most likely to be circulating in the northern hemisphere by the next “flu season”, ie, the fall of 2017.
Six months is the minimum amount of time that it takes multinational vaccine corporations to grow enough of the viruses in fertilized chicken eggs to fulfill the anticipated demand for flu vaccines six months later.
Such a guesswork process is actually a crapshoot and the choices made are highly unlikely to match the new viral culprits that may or may not be circulating up north next fall. I suppose the vaccine industries in the southern hemisphere look at America’s flu statistics when they choose their vaccine ingredients for their next flu season.
Wild Influenza Viruses can Mutate Into Ineffective Components Before they get into the Vaccines
Well, the flu season of 2017 was another bust, but you wouldn’t know it from the CDC’s Tom Frieden, the broadcast media and other industry promotions that tried to convince us it was a grand success and worth the risks and expense. The guesswork had failed again; and there were essentially no viral matches between the viral antigens chosen and the several flu viruses commonly circulating in the population. The H3N2 influenza virus component, for example, had apparently mutated into ineffectiveness by the time enough of them had been grown in the egg cultures. (See above Ian A. Wilson reference.)
Only about 1% of Americans that submitted to flu shots in 2017 received any benefit from the shots, but 100% of them risked suffering the many potential side effects of the vaccinations.
Most important among the adverse effects were those often unrecognized toxicity from the neurotoxic, immunotoxic and kidney toxic mercury preservative (thimerosal) that is still in the multidose vials. What happens to patients who simultaneously received their pneumovax shots (that contains aluminum, which is neurotoxic, blood-brain barrier toxic and immunotoxic) will never be investigated in the US because there is a 1986 Reagan-era federal law that forbids lawsuits to be filed against vaccine manufacturers. Hence there is no impetus to find out about such inconvenient facts.
So, since there was a vague suspicion on the part of the public about the failed flu shot campaign, the CDC and Big Pharma statisticians felt that they had to do something to convince the duped masses that they hadn’t wasted their time, mind, money and health by submitting to the vaccine. In a profit-minded nation such as the US, where the stock market is king and the public health is secondary, the highly profitable annual flu vaccination campaigns have to be perpetuated or else the share prices (and the honor) of the involved pharma and medical companies might suffer.
And so the entities that profit from America’s over-vaccination agendas tried to save face by retrospectively claiming that there was a “60% effectiveness rate” for flu shot recipients.
Claiming a 60% Effectiveness Rate for Last Year’s Flu Shot Qualifies as one of Mark Twain’s “Damn Lies”
The big problem is that “60% effectiveness” is a relative risk reduction (RRR) statistic, which is a “damn lie”. The actual “effectiveness rate” for flu shots in 2017 was closer to 1% when one calculates the absolute risk reduction (ARR)
Exposing again the truth of Twain’s “lies, damn lies and statistics”, last year’s flu shots actually failed to protect 99% of vaccine recipients. In other words, the ARR for those who took the flu shot last year was 1%, a pretty dismal figure.
Both the CDC and Big Pharma are notorious for using deceptive statistics which drastically over-emphasize meager benefits and simultaneously under-report (or even fail to report) serious adverse effects or serious lack of effectiveness. What they are doing is bamboozlement at its most sophisticated – and diabolical.